October 11, 2011

Drug maker Warner Chilcott's diversified portfolio of drugs will help it weather generic challenges to its patents, according to a new report by Zacks Investment Research.

November 7, 2010

Quarterly revenue for Warner Chilcott during the third quarter primarily was driven by the company's...